Chapters

Transcript

Video

What is the evidence that more personalized, gene-directed cancer therapy, in which specific molecular drivers of a patient's disease are aligned with specific therapy, will improve patient outcomes?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Jianming Xu, MD

Professor Jianming Xu, MD

Affiliated Hospital Cancer Center
Academy of Military Medical Sciences
Beijing, China